What are the treatment options for migraines?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Options for Migraines

For acute, episodic, moderate to severe migraine headaches, a stepped care approach should be used, starting with NSAIDs for mild to moderate attacks and progressing to triptans or combination therapy for moderate to severe attacks. 1, 2

First-Line Acute Treatment Options

  • Begin with NSAIDs (aspirin, celecoxib, diclofenac, ibuprofen, or naproxen) or acetaminophen at appropriate dosages for mild to moderate migraine attacks 1
  • Consider increasing the dosage of NSAIDs or acetaminophen (without exceeding maximum daily dose) if pain relief is insufficient 1
  • For patients who don't achieve sufficient relief with NSAIDs or acetaminophen, add a triptan (almotriptan, eletriptan, frovatriptan, naratriptan, rizatriptan, sumatriptan, or zolmitriptan) 1, 2
  • Combination therapy (triptan plus NSAID or acetaminophen) is more effective than monotherapy and should be initiated as soon as possible after migraine onset 1, 2
  • Triptans are most effective when taken early in an attack while headache is still mild 2

Advanced Treatment Options

  • For patients who fail all available triptans or have contraindications to triptans, consider: 1, 2
    • CGRP antagonists (gepants): rimegepant, ubrogepant, or zavegepant
    • Ergot alkaloids: dihydroergotamine (DHE)
    • Ditans: lasmiditan
  • For patients with severe nausea or vomiting, consider: 1, 2
    • Non-oral routes of administration (e.g., subcutaneous sumatriptan injection)
    • Adding antiemetics like metoclopramide or prochlorperazine

Important Cautions and Contraindications

  • Avoid opioids and butalbital-containing medications for migraine treatment 1, 2
  • Be aware of medication overuse headache risk: limit acute medication use to ≤15 days/month for NSAIDs and ≤10 days/month for triptans 1, 2
  • Triptans are contraindicated in patients with: 3, 4
    • Coronary artery disease or Prinzmetal's variant angina
    • History of stroke or TIA
    • Uncontrolled hypertension
    • Wolff-Parkinson-White syndrome or other cardiac accessory conduction pathway disorders
  • Monitor for serotonin syndrome when combining triptans with SSRIs, SNRIs, TCAs, or MAO inhibitors 3, 4

Preventive Treatment Considerations

  • Consider preventive therapy for patients with: 2, 5
    • Two or more attacks per month producing disability
    • Attacks lasting 3+ days per month
    • Contraindication to or failure of acute treatments
    • Use of acute medication more than twice per week
  • First-line preventive options include: 5
    • Beta-blockers (propranolol, metoprolol)
    • Anticonvulsants (topiramate, divalproex, valproate)
    • CGRP receptor antagonists
  • For chronic migraine, consider onabotulinumtoxinA injections 5

Non-Pharmacological Approaches

  • Lifestyle modifications are important adjuncts to pharmacological treatment: 1, 2, 6
    • Maintain regular meals and hydration
    • Ensure sufficient and consistent sleep
    • Engage in regular physical activity, preferably moderate to intense aerobic exercise
    • Manage stress with relaxation techniques or mindfulness practices
    • Consider weight loss for overweight or obese patients
  • Identify and manage individual migraine triggers 6
  • Consider complementary approaches such as acupuncture, biofeedback, and dietary supplements (riboflavin, coenzyme Q10, magnesium) for patients interested in non-pharmacological options 6, 5

Monitoring and Follow-up

  • Use headache diaries to monitor treatment efficacy, identify analgesic overuse, and track migraine progression 2
  • If preventive treatment doesn't provide adequate response after a reasonable trial period (typically 2-3 months), consider switching to another option 2
  • Educate patients about medication overuse headache and the importance of limiting acute medication use 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Migraine Treatment Strategies

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Migraine Headache Prophylaxis.

American family physician, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.